TipRanks
Go Ultimate55% OFF

Compare Prime Medicine, Inc. (PRME) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
PRMEPrime Medicine, Inc.$4.72$856.10M-4.298.51%Strong BuyUnlock the PRME analyst price target with TipRanks PremiumPRMEUnlock the PRME top-analyst price target with TipRanks Premium
IMTXImmatics$7.20$1.08B-4.04-30.90%Strong BuyUnlock the IMTX analyst price target with TipRanks PremiumPRME vs IMTXUnlock the IMTX top-analyst price target with TipRanks Premium
RLAYRelay Therapeutics$18.35$4.02B-11.69150.00%Strong BuyUnlock the RLAY analyst price target with TipRanks PremiumPRME vs RLAYUnlock the RLAY top-analyst price target with TipRanks Premium
TSHATaysha Gene Therapies$4.13$1.35B-9.77-15.89%Strong BuyUnlock the TSHA analyst price target with TipRanks PremiumPRME vs TSHAUnlock the TSHA top-analyst price target with TipRanks Premium
SANASana Biotechnology$2.57$769.36M-3.38-47.55%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumPRME vs SANAUnlock the SANA top-analyst price target with TipRanks Premium
UPBUpstream Bio, Inc.$3.41$186.77M-1.18-86.77%Strong BuyUnlock the UPB analyst price target with TipRanks PremiumPRME vs UPBUnlock the UPB top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PRMEPrime Medicine, Inc.4.720.163.51%
IMTXImmatics7.20-2.48-25.62%
RLAYRelay Therapeutics18.3511.41164.41%
TSHATaysha Gene Therapies4.13-0.33-7.40%
SANASana Biotechnology2.57-2.00-43.76%
UPBUpstream Bio, Inc.3.41-21.61-86.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts